In Vitro Brain Organoids and Computational Models to Study Cell Death in Brain Diseases
- PMID: 35776358
- DOI: 10.1007/978-1-0716-2409-8_17
In Vitro Brain Organoids and Computational Models to Study Cell Death in Brain Diseases
Abstract
Understanding the mechanisms underlying the formation and progression of brain diseases is challenging due to the vast variety of involved genetic/epigenetic factors and the complexity of the environment of the brain. Current preclinical monolayer culture systems fail to faithfully recapitulate the in vivo complexities of the brain. Organoids are three-dimensional (3D) culture systems that mimic much of the complexities of the brain including cell-cell and cell-matrix interactions. Complemented with a theoretical framework to model the dynamic interactions between different components of the brain, organoids can be used as a potential tool for studying disease progression, transport of therapeutic agents in tissues, drug screening, and toxicity analysis. In this chapter, we first report on the fabrication and use of a novel self-filling microwell arrays (SFMWs) platform that is self-filling and enables the formation of organoids with uniform size distributions. Next, we will introduce a mathematical framework that predicts the organoid growth, cell death, and the therapeutic responses of the organoids to different therapeutic agents. Through systematic investigations, the computational model can identify shortcomings of in vitro assays and reduce the time and effort required to improve preclinical tumor models' design. Lastly, the mathematical model provides new testable hypotheses and encourages mathematically driven experiments.
Keywords: Brain tissue models; In silico modeling; Neuronal cell death; Organoids.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Seyfoori A, Amereh M, Dabiri SMH, Askari E, Walsh T, Akbari M (2021) The role of biomaterials and three dimensional (3D) in vitro tissue models in fighting against COVID-19. Biomater Sci 9:1217 - DOI
-
- Zhang B, Korolj A, Lai BFL, Radisic M (2018) Advances in organ-on-a-chip engineering. Nat Rev Mater 3:257–278 - DOI
-
- Lim M, Xia Y, Bettegowda C, Weller M (2018) Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol 15:422–442 - DOI
-
- Shojaei S, Koleini N, Samiei E, Aghaei M, Cole LK, Alizadeh J, Islam MI, Vosoughi AR, Albokashy M, Butterfield Y (2019) Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes. FEBS J 287:1005 - DOI
-
- Stathias V, Jermakowicz AM, Maloof ME, Forlin M, Walters W, Suter RK, Durante MA, Williams SL, Harbour JW, Volmar C-H (2018) Drug and disease signature integration identifies synergistic combinations in glioblastoma. Nat Commun 9:1–13 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical